mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-11 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-10 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-10 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-10 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-09 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-09 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-09 |